HR Execs on the Move

XORTX

www.xortx.com

 
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.xortx.com
  • 4000, 421 - 7th Avenue SouthWest
    Calgary, AB CAN T2P 4K9
  • Phone: 403.455.7727

Executives

Name Title Contact Details
Amar Keshri
 Chief Financial Officer Profile
James Fairbairn
 Chief Financial Officer Profile

Similar Companies

Rehab 2 Perform

R2P creates a unique physical therapy experience, offering our blend of performance, return to sport, physical therapy, dry needling and injury prevention.

Helvoet Pharma USA

Helvoet Pharma USA is a Pennsauken, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eisai

Eisai Inc. is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Defined Health

Defined Health is a Florham Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nitto Avecia Pharma Services

A Systematic Approach To Extractables And Leachables: A Review Of Guidance From The Industry